2 completed, 1 not yet recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Refractory Colorectal Cancer: new trials by email Literature Review of Refractory Colorectal Cancer trials Research Report on Refractory Colorectal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study High- and Low-Dose Radiotherapy, Anti-Angiogenic TKI and Anti-PD-1 Therapy - Refractory Colorectal Cancer, Radiotherapy-Induced Immune Priming | Phase 2 | Not yet recruiting | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 33 | 2026-04-01 | 2026-03-12 |
| Fruquintinib in Refractory Metastatic Colorectal Cancer: A Real-world Study Fruquintinib - Colorectal Cancer, Refractory Colorectal Cancer | Completed | Fudan University | 520 | 2021-01-01 | 2024-01-11 | |
| Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer Glutaminase Inhibitor CB-839, Panitumumab, Irinotecan Hydrochloride (phase I only) - Colorectal Cancer, Metastatic Colorectal Cancer | Phase 1 / Phase 2 | Completed | Vanderbilt-Ingram Cancer Center | 29 | 2017-08-23 | 2024-08-30 |
Colonic Diseases (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Rectal Diseases (3)
Antineoplastic Agents (1) · CB-839 (1) · Diagnostic Imaging (1) · HMPL-013 (1) · Irinotecan (1) · Panitumumab (1) · Radiotherapy (1)
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (1) · Fudan University (1) · Vanderbilt-Ingram Cancer Center (1)
China (1) · United States (1)
Jianmin Xu (1) · Jordan Berlin, MD (1)